ProfileGDS4718 / 225427_s_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 94% 92% 92% 94% 93% 95% 96% 94% 92% 94% 95% 93% 96% 95% 96% 93% 93% 95% 97% 88% 93% 94% 93% 95% 93% 95% 94% 93% 93% 96% 96% 93% 93% 92% 97% 98% 96% 94% 94% 93% 94% 93% 95% 97% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]9.9953194
GSM549102patient 115, normal, homogenized [OPG study]9.6037892
GSM549104patient 119, normal, homogenized [OPG study]9.6886792
GSM549108patient 138, normal, homogenized [OPG study]10.048494
GSM549119patient 077, normal, homogenized [OPG study]9.7045793
GSM549133patient 032, cancer, homogenized [OPG study]10.384895
GSM549139patient 042, cancer, homogenized [OPG study]10.32696
GSM549099patient 107, normal, homogenized [OPG study]9.8950994
GSM549109patient 139, normal, homogenized [OPG study]9.6643892
GSM549110patient 046, normal, homogenized [OPG study]9.9988294
GSM549114patient 063, normal, homogenized [OPG study]10.363195
GSM549122patient 082, normal, homogenized [OPG study]9.8486693
GSM549134patient 033, cancer, homogenized [OPG study]10.502296
GSM549136patient 036, cancer, homogenized [OPG study]10.169995
GSM549140patient 044, cancer, homogenized [OPG study]10.366696
GSM549111patient 047, normal, homogenized [OPG study]9.8399793
GSM549113patient 057, normal, homogenized [OPG study]10.049493
GSM549132patient 031, cancer, homogenized [OPG study]10.17595
GSM549137patient 038, cancer, homogenized [OPG study]10.601997
GSM549142patient 047, cancer, homogenized [OPG study]8.4460888
GSM549100patient 110, normal, homogenized [OPG study]9.7174293
GSM549107patient 135, normal, homogenized [OPG study]10.047494
GSM549115patient 068, normal, homogenized [OPG study]9.8970193
GSM549116patient 072, normal, homogenized [OPG study]10.272595
GSM549120patient 078, normal, homogenized [OPG study]9.8067993
GSM549131patient 030, cancer, homogenized [OPG study]10.256695
GSM549118patient 074, normal, homogenized [OPG study]10.047894
GSM549129patient 027, cancer, homogenized [OPG study]9.6147593
GSM549123patient 088, normal, homogenized [OPG study]9.7393
GSM549124patient 006, cancer, homogenized [OPG study]10.243196
GSM549126patient 015, cancer, homogenized [OPG study]10.368496
GSM549128patient 025, cancer, homogenized [OPG study]9.8215993
GSM549103patient 117, normal, homogenized [OPG study]9.5927693
GSM549117patient 073, normal, homogenized [OPG study]9.6970392
GSM549138patient 041, cancer, homogenized [OPG study]10.75297
GSM549141patient 045, cancer, homogenized [OPG study]11.299698
GSM549130patient 028, cancer, homogenized [OPG study]10.237596
GSM549101patient 111, normal, homogenized [OPG study]9.8604994
GSM549105patient 128, normal, homogenized [OPG study]9.9638594
GSM549106patient 134, normal, homogenized [OPG study]9.9034593
GSM549112patient 048, normal, homogenized [OPG study]10.178194
GSM549125patient 011, cancer, homogenized [OPG study]9.5953293
GSM549127patient 024, cancer, homogenized [OPG study]10.043895
GSM549135patient 035, cancer, homogenized [OPG study]11.092797